Relay Medical Corp. reported on the development of a new home and small business testing system based on the Company’s Pharmatrac platform. The universal device and mobile app allow for use of lateral flow diagnostic kits, including COVID-19 antigen and antibody tests. The new mobile application and device shares the intellectual property and technology synergies between Relay’s medication management device, Pharmatrac, and FRR’s rapid testing and tracking platform, Fionet, which has recently been deployed in a wide variety of settings including Airports1, Sporting Events2, and with USAID to 144 remote locations in Africa.3 The Company is now involved in discussions and early-stage engagements with potential strategic partners while continuing product development, conducting demos, small pilots, and internal trials to refine custom applications specific to industry and regional integrations. Relay brings together the capabilities of its medication management device, Pharmatrac, with FRR’s Fionet cloud-based rapid testing and tracking platform to introduce an inexpensive and user-friendly home, small business, and community testing system accessible by mobile app or Pharmatrac device. The new mobile and device application utilizes the core machine vision and AI functionalities of Pharmatrac to improve testing compliance and quality in moderate throughput settings. In many regions, home testing is not approved due to concerns from health authorities over compliance to testing protocols by users. Relay and FRR bring together the complementary technologies to minimize compliance risk, ensure adherence to proper Instructions For Use (IFU) of the test, and deliver lab-quality results in remote locations. The platform also enables remote healthcare professionals to review and interpret results while increasing patient accessibility and guidance if further action is required. This compliments the Fionet high throughput solution based on the Deki device, which is designed to process large volumes at the capacity of 60 tests an hour for high density settings such as testing centers, large workplaces, entertainment events and travel ports. How the Home Testing Platform Works: Users receive a package to their home or small business containing the test kit(s) with instructions, The kit includes a home appliance that is used to capture the image of the lateral flow test, Users scan a QR code with their mobile device to open a web portal that walks them through the process of self-administering the test, Users then place the lateral flow test in the appliance and an image is captured, The image is analyzed using a proprietary machine vision algorithm to determine the result which is then confirmed by a trained healthcare professional, Users receive a notification of the test result and information if any further action is required, Users can use the electronic receipt to show their result as needed and Results can also be reported to appropriate health authorities with advanced data analytics.